EP 1558609 A2 20050803 - KINASE INHIBITORS
Title (en)
KINASE INHIBITORS
Title (de)
KINASE-HEMMER
Title (fr)
INHIBITEURS DE KINASE
Publication
Application
Priority
- US 0334100 W 20031024
- US 42231302 P 20021030
Abstract (en)
[origin: WO2004041164A2] The present invention relates to compounds which inhibit, regulate and/or modulate kinase signal transduction, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, retinal ischemia, macular edema, diabetic retinopathy, inflammatory diseases, and the like in mammals.
IPC 1-7
IPC 8 full level
A61K 31/427 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP)
A61P 3/10 (2017.12); A61P 9/10 (2017.12); A61P 15/00 (2017.12); A61P 15/02 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 43/00 (2017.12); C07D 417/12 (2013.01); C07D 417/14 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004041164 A2 20040521; WO 2004041164 A3 20041007; AU 2003285007 A1 20040607; CA 2503715 A1 20040521; EP 1558609 A2 20050803; EP 1558609 A4 20080528; JP 2006507302 A 20060302
DOCDB simple family (application)
US 0334100 W 20031024; AU 2003285007 A 20031024; CA 2503715 A 20031024; EP 03779322 A 20031024; JP 2004550143 A 20031024